Uncategorized

05/02/2024|UncategorizedRostock, 2024 May 02,  SensID GmbH, a leading provider of quality assurance materials for the diagnostic industry, proudly announces the launch of its groundbreaking metagenome control material. This innovative solution promises to revolutionize molecular healthcare through the rapid identification of thousands of microbes. Traditional diagnostic methods often take precious time to identify a limited number of pathogens. In contrast, SensID’s new metagenome control material enables the detection of bacteria, DNA viruses, fungi and parasites within a single day using next-generation…

11/15/2023|UncategorizedRostock, 2023 Nov 23 – SensID GmbH, a leading provider of quality control materials for molecular diagnostic testing, is proud to announce the launch of a “ESR1 Reference Set (1% AF cfDNA).” This cutting-edge product is specifically designed as quality control material for laboratories currently developing/implementing ESR1 assays, making SensID the first in the market to offer such a solution. The ESR1 reference set plays a crucial role in ensuring the accuracy and reliability of ESR1 mutation assays investigating cell-free…

07/15/2020|Uncategorized Rostock and Lund, 15 of July 2020 SensID GmbH, headquartered in Rostock, Germany, is a specialist for development and production of reference control materials for clinical genomics. SAGA Diagnostics AB, headquartered in Lund, Sweden, is a cancer genomics company focused on precision oncology and ultrasensitive liquid biopsy monitoring of cancer patients.  Today the two companies announce a collaboration to develop Ultra-Low Allelic Frequency (AF) controls. The demand for liquid biopsy solutions and accurate testing is growing rapidly and has already resulted…